In the 1980s, AD entered the “molecular age” when a small neuropeptide called the amyloid β protein (Aβ) was found to be the key fibrillar component of senile plaques [11–14] and the microtubule binding protein tau to be the key fibrillar component of NFTs [15, 16]. This evidence concerns the gene MAPT and Alzheimer disease.